The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and S-1 (GS) for borderline resectable (BR)/unresectable (UR) pancreatic cancer (CAP-003 study).
 
Hideyuki Yoshitomi
No Relationships to Disclose
 
Shigetsugu Takano
No Relationships to Disclose
 
Shingo Kagawa
No Relationships to Disclose
 
Katsunori Furukawa
No Relationships to Disclose
 
Tsukasa Takayashiki
No Relationships to Disclose
 
Satoshi Kuboki
No Relationships to Disclose
 
Masaru Miyazaki
No Relationships to Disclose
 
Masayuki Ohtsuka
No Relationships to Disclose